Raymond James Financial Services Advisors, Inc. Sage Therapeutics, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 21, 2020	SELL	$26.15 - $77.24 $106,195 - $313,671	-4,061 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$60.18 - $154.77 $6,740 - $17,334	-112 Reduced 2.68%	4,061 $293,000
Q3 2019 Nov 07, 2019	SELL	$140.29 - $189.96 $2,525 - $3,419	-18 Reduced 0.43%	4,173 $585,000
Q2 2019 Aug 06, 2019	SELL	$157.85 - $183.09 $68,349 - $79,277	-433 Reduced 9.36%	4,191 $767,000
Q1 2019 May 06, 2019	SELL	$89.33 - $163.65 $29,032 - $53,186	-325 Reduced 6.57%	4,624 $735,000
Q4 2018 Feb 11, 2019	SELL	$81.94 - $139.71 $25,073 - $42,751	-306 Reduced 5.82%	4,949 $474,000
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $66,430 - $81,308	481 Added 10.08%	5,255 $742,000
Q2 2018 Jul 30, 2018	BUY	$140.36 - $175.76 $323,950 - $405,654	2,308 Added 93.59%	4,774 $747,000
Q1 2018 Apr 16, 2018	BUY	$152.15 - $192.33 $155,953 - $197,138	1,025 Added 71.13%	2,466 $397,000
Q4 2017 Feb 09, 2018	SELL	$60.72 - $167.34 $400,387 - $1.1 Million	-6,594 Reduced 82.07%	1,441 $237,000
Q3 2017 Oct 26, 2017	SELL	$61.4 - $88.52 $39,725 - $57,272	-647 Reduced 7.45%	8,035 $501,000
Q2 2017 Aug 15, 2017	BUY	N/A	8,682	8,682 $691,000

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $292M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account